None listed
Conditions
Interventions
Sponsors
APO PLUS STATION CO., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: [1] Healthy males and females in the age more than 20 and less than 70 years. [2] Subjects who can submit the written informed consent form.
Exclusion criteria
Exclusion criteria: [1] Subjects who are on treatment for a serious illness. [2] Subjects who are being treated or have a history of malignant tumors, heart failure, or myocardial infarction. [3] Subjects with food allergies or those who may be allergic to the test food. [4] Subjects who regularly use licensed drugs or quasi-drugs that may affect the study and who are unable to discontinue their intake during the study period. [5] Subjects who regularly use health foods that may affect the study and who are unable to discontinue their intake during the study period. [6] Subjects who have had blood drawn or donated more than 200 mL of blood within a month or more than 400 mL within 3 months before the screening test. [7] Subjects who may be unable to maintain their daily lifestyle. [8] Subjects who are pregnant or breastfeeding or planning to become pregnant during the study period. [9] Subjects who participated in other clinical trials within 3 months prior to the date of consent, or plan to participate in other clinical trials during the study period. [10] Subjects who are judged as ineligible for the study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expression rate of side effects | — |
Secondary
| Measure | Time frame |
|---|---|
| [1] Expression rate of adverse events [2] Results of physical examination, clinical examination (blood test, urinalysis) | — |
Countries
Japan
Contacts
Public ContactSatomi Uetake
APO PLUS STATION CO., LTD. Clinical Operations Dept., CRO Business div.
Outcome results
None listed